JP2015514086A5 - - Google Patents

Download PDF

Info

Publication number
JP2015514086A5
JP2015514086A5 JP2015503348A JP2015503348A JP2015514086A5 JP 2015514086 A5 JP2015514086 A5 JP 2015514086A5 JP 2015503348 A JP2015503348 A JP 2015503348A JP 2015503348 A JP2015503348 A JP 2015503348A JP 2015514086 A5 JP2015514086 A5 JP 2015514086A5
Authority
JP
Japan
Prior art keywords
hemoglobin
conjugate according
peg
hemoglobin conjugate
anemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2015503348A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015514086A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/032694 external-priority patent/WO2013148375A1/en
Publication of JP2015514086A publication Critical patent/JP2015514086A/ja
Publication of JP2015514086A5 publication Critical patent/JP2015514086A5/ja
Pending legal-status Critical Current

Links

JP2015503348A 2012-03-29 2013-03-15 ジアスピリン架橋pegヘモグロビン Pending JP2015514086A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261617639P 2012-03-29 2012-03-29
US61/617,639 2012-03-29
PCT/US2013/032694 WO2013148375A1 (en) 2012-03-29 2013-03-15 Diaspirin crosslinked pegylated hemoglobin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2019005963A Division JP6668515B2 (ja) 2012-03-29 2019-01-17 ジアスピリン架橋pegヘモグロビン

Publications (2)

Publication Number Publication Date
JP2015514086A JP2015514086A (ja) 2015-05-18
JP2015514086A5 true JP2015514086A5 (cg-RX-API-DMAC7.html) 2016-04-28

Family

ID=49261107

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2015503348A Pending JP2015514086A (ja) 2012-03-29 2013-03-15 ジアスピリン架橋pegヘモグロビン
JP2019005963A Expired - Fee Related JP6668515B2 (ja) 2012-03-29 2019-01-17 ジアスピリン架橋pegヘモグロビン

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2019005963A Expired - Fee Related JP6668515B2 (ja) 2012-03-29 2019-01-17 ジアスピリン架橋pegヘモグロビン

Country Status (10)

Country Link
US (1) US10029001B2 (cg-RX-API-DMAC7.html)
EP (1) EP2830638B1 (cg-RX-API-DMAC7.html)
JP (2) JP2015514086A (cg-RX-API-DMAC7.html)
KR (1) KR102144139B1 (cg-RX-API-DMAC7.html)
CN (2) CN109731098A (cg-RX-API-DMAC7.html)
AU (1) AU2013240141B2 (cg-RX-API-DMAC7.html)
CA (1) CA2908236C (cg-RX-API-DMAC7.html)
HK (1) HK1207560A1 (cg-RX-API-DMAC7.html)
MX (1) MX358785B (cg-RX-API-DMAC7.html)
WO (1) WO2013148375A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3233803T (lt) * 2014-12-19 2019-04-10 Aragon Pharmaceuticals, Inc. Diariltiohidantoino junginio gamybos būdas
CN105017515A (zh) * 2015-07-20 2015-11-04 湖南华腾制药有限公司 聚乙二醇修饰物的制备方法
CN106421805B (zh) * 2016-09-14 2019-06-04 中国人民解放军军事医学科学院野战输血研究所 一种右旋糖酐交联血红蛋白氧载体及其制备方法与应用
EP3655019A4 (en) 2017-07-18 2021-04-21 Virtech Bio, Inc. BLOOD SUBSTITUTES INCLUDING HEMOGLOBIN AND METHODS OF MANUFACTURING
US11857605B2 (en) 2021-03-01 2024-01-02 Billion King International Limited Thiosuccinyl-crosslinked hemoglobin conjugates and methods of use and preparation thereof
CN114146165B (zh) * 2021-12-02 2022-08-12 润方(北京)生物医药研究院有限公司 一种聚合血红蛋白在制备防治呼吸衰竭药物中的应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529719A (en) * 1983-05-04 1985-07-16 Tye Ross W Modified crosslinked stroma-free tetrameric hemoglobin
EP0206448B1 (en) * 1985-06-19 1990-11-14 Ajinomoto Co., Inc. Hemoglobin combined with a poly(alkylene oxide)
CA1312009C (en) 1986-11-10 1992-12-29 Carl W. Rausch Extra pure semi-synthetic blood substitute
US5234903A (en) 1989-11-22 1993-08-10 Enzon, Inc. Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute
US5585484A (en) 1995-04-19 1996-12-17 Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University Hemoglobin crosslinkers
US6627738B2 (en) 1995-09-15 2003-09-30 Duke University No-modified hemoglobins and uses therefor
US7019117B2 (en) 2001-07-19 2006-03-28 Albert Einstein College Of Medicine Of Yeshiva University Size enhanced hemoglobins: surface decoration and crosslinking of the protein with polyoxy alkylene glycols
US20050164915A1 (en) * 2002-04-01 2005-07-28 Sangart, Inc. Compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US20030153491A1 (en) 2002-01-11 2003-08-14 Winslow Robert M. Methods and compositions for oxygen transport comprising a high oxygen affinity modified hemoglobin
US7144989B2 (en) 2002-03-25 2006-12-05 Albert Einstein College Of Medicine Of Yeshiva University Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof
AU2003299700B2 (en) 2002-12-23 2009-03-26 Albert Einstein College Of Medicine Of Yeshiva University Modified hemoglobin and methods of making same
KR100512483B1 (ko) 2003-05-07 2005-09-05 선바이오(주) 신규한 폴리에틸렌글리콜-말레이미드 유도체의 합성방법
DE602005023191D1 (de) * 2004-08-31 2010-10-07 Sangart Inc Verfahren zur verbesserung der hämodynamischen stabilität mit sauerstoff-tragenden zusammensetzungen
EP1863503B1 (en) 2005-03-07 2019-05-22 Sangart, Inc. Composition for delivering carbon monoxide (co) and nitric ozide (no) co to tissue using heme proteins as carriers
WO2006135740A1 (en) 2005-06-10 2006-12-21 Albert Einstein College Of Medicine Of Yeshiva University Pegylated hemoglobin and albumin and uses thereof
US7504377B2 (en) * 2006-10-23 2009-03-17 Ikor, Inc. Nitric oxide-blocked cross-linked tetrameric hemoglobin
WO2011106396A1 (en) 2010-02-25 2011-09-01 Sangart, Inc. Methods for preparing peg-hemoglobin conjugates using reduced reactant ratios
US20130052232A1 (en) * 2011-08-31 2013-02-28 Bing Lou Wong Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking

Similar Documents

Publication Publication Date Title
JP2015514718A5 (cg-RX-API-DMAC7.html)
US12329822B2 (en) Antimicrobial tailored chitosan
Cui et al. Molecular engineering of antimicrobial peptide (AMP)–polymer conjugates
CN104411807B (zh) 琥珀酰亚胺活化型硝酰化合物及其用于蛋白质硝酰化的使用方法
JP2016521258A5 (cg-RX-API-DMAC7.html)
CN106714820A (zh) 选择素及icam/vcam肽配体偶联物
JP6799823B2 (ja) ポリ(l−アルギニン)セグメント含有ブロック共重合体とポリアニオン性ポリマーのポリイオンコンプレックス
EP3016693A1 (en) Dissolvable hydrogel compositions for wound management and methods of use
JP5657011B2 (ja) カテコールポリエチレングリコール誘導体と蛋白質またはペプチドの接合体、及びこれの製造方法
TW200812572A (en) Polymer conjugate of taxane
JP6668515B2 (ja) ジアスピリン架橋pegヘモグロビン
US11529424B2 (en) Synthetic bioconjugates
EP2838550A1 (en) Polymeric conjugates of c1-inhibitors
JP2017523781A5 (cg-RX-API-DMAC7.html)
JP2020534840A5 (cg-RX-API-DMAC7.html)
WO2012067138A1 (ja) 新規なシチジン系代謝拮抗剤の高分子誘導体
JP2026040471A (ja) キトサン-核酸ナノ粒子の可逆的コーティング及びその使用方法
JP6657070B2 (ja) ポリアルキレンオキシド吉草酸ヘモグロビン接合体
JP6358797B2 (ja) 癌を処置するためのウミロリムスおよびその誘導体の使用
CN103316354A (zh) 肿瘤靶向多肽-聚乙二醇-聚乳酸复合物及制备方法和应用
JP5281358B2 (ja) 高分子、経上皮吸収促進剤、及び医薬用製剤
CN102617852A (zh) 马来酰亚胺-聚谷氨酸-天冬氨酸聚合物和其复合物、及其制备方法和用途
JP7773169B2 (ja) ポリオキサゾリン結合アルブミン、人工血漿増量剤及び出血ショックの蘇生液
WO2016013911A1 (ko) 페길화된 인터페론 -베타 변이체
HK1238155A1 (en) Selectin and icam/vcam peptide ligand conjugates